Association analysis of tyrosine kinase FYN gene polymorphisms in asthmatic children

Aleksandra Szczepankiewicz1, Anna Breborowicz, Maria Skibińska

  • 1Department of Pediatric Pulmonology, Allergy and Clinical Immunology, Poznan University of Medical Sciences, Poznan, Poland. alszczep@amp.edu.pl

Abstract

Insights

Genetic variations in the FYN gene, specifically the -93A/G polymorphism, are associated with the presence and severity of allergic asthma in children. Further research may clarify the role of FYN gene polymorphisms in asthma development.

Area of Science:

  • Immunogenetics
  • Molecular Biology
  • Respiratory Medicine

Background:

  • FYN is a nonreceptor tyrosine kinase crucial in early inflammatory cell signaling.
  • Tyrosine kinase inhibitors show anti-inflammatory effects in asthma models.
  • Previous studies have not investigated FYN gene polymorphisms in relation to asthma.

Purpose of the Study:

  • To investigate the association between three specific FYN gene polymorphisms (-93A/G, Intron10+37C/T, Ex12+894T/G) and allergic asthma.
  • To determine if these polymorphisms correlate with asthma severity in pediatric patients.

Main Methods:

  • Genotyping of 120 pediatric asthma patients (ages 6-18) and 187 healthy controls using PCR-RFLP.
  • Asthma diagnosis confirmed by clinical presentation, lung function, skin prick tests, and IgE levels.

Main Results:

  • The -93A/G polymorphism was significantly associated with asthma presence (p=0.014) and severe asthma (p=0.042).
  • The Ex12+894T/G polymorphism showed association with asthma in the overall group (p=0.067) but not severe cases.
  • No significant association was found for the Intron10+37T/C polymorphism.

Conclusions:

  • FYN gene polymorphisms, particularly -93A/G, may be linked to allergic asthma.
  • These findings suggest a potential genetic contribution of FYN to asthma pathogenesis.
  • Further studies are warranted to elucidate the precise role of FYN in asthma.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...